Companies: 10,795·Total market cap: $144.5T
CymaBay Therapeutics, Inc.

CymaBay Therapeutics, Inc.

CBAYNASDAQHealthcare
$32.48
+$0.01(+0.03%)
Market Cap$3.7B
P/E Ratio
52W High$32.5
52W Low$7.261
Overview

CymaBay Therapeutics, Inc.(CBAY)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CBAY · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2023-122022-122021-122020-122019-12
Revenue
Revenue$31.07M$0.00M$0.00M$0.00M$0.00M
Cost of Revenue$0.68M$0.71M$0.69M$0.63M$0.80M
Gross Profit$30.39M($0.71M)($0.69M)($0.63M)($0.80M)
Gross Margin %(computed)97.81%
Operating Expenses
R&D Expenses$80.12M$68.00M$64.54M$35.88M$83.84M
G&A Expenses$51.95M$25.12M$23.04M$17.43M$19.24M
Total Operating Expenses$132.07M$93.11M$87.58M$53.31M$103.08M
Operating Income($101.68M)($93.11M)($87.58M)($52.60M)($108.15M)
Operating Margin %(computed)-327.23%
Interest Income$13.49M$2.02M$0.17M$1.62M$5.34M
Interest Expense$18.95M$14.91M$2.58M$0.00M$0.00M
Income Before Tax($105.37M)($106.00M)($90.00M)($50.99M)($102.81M)
Income Tax Expense$0.00M$12.89M$2.58M($2.32M)($0.57M)
Net Income($105.37M)($118.89M)($92.58M)($48.66M)($102.24M)
Net Margin %(computed)-339.10%
Per Share & EBITDA
EPS (Basic)$-0.99$-1.35$-1.30$-0.71$-1.53
Wtd Avg Shares106.20M87.80M71.06M68.89M67.03M
EBITDA($85.74M)($92.40M)($86.73M)($50.35M)($108.15M)
EBITDA Margin %(computed)-275.94%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解CymaBay Therapeutics, Inc.

关于CymaBay Therapeutics, Inc.(CBAY)损益表

CymaBay Therapeutics, Inc.(CBAY)损益表数据来源于SEC Form 10-K及10-Q申报文件。2023财年,CBAY实现营收$0.03B,毛利润$0.03B(毛利率97.81%),净利润($0.11B)(净利率-339.10%)。

常见问题

CBAY · 4 问

CymaBay Therapeutics, Inc.(CBAY)2023财年营收为$0.03B,同比up—%。

CBAY revenueCBAY salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08